finvector.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# See http://www.robotstxt.org/robotstxt.html for documentation on how to use the robots.txt | ||
Meta Tags
| Title | Home - |
| Description | A world leader in cGMP manufacturing of Viral-Based Gene Therapy Our Story Management Services + Cell banking and Viral seed stocks Research & Development Platform Process Development / Scale Up Assay Development and An |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 185.6.181.240 |
| Location | Finland |
Related Websites
| Site | Rank |
More to Explore
finvector.com Valuation
|
US$478,185
Last updated: 2023-05-11 01:52:24
finvector.com has Semrush global rank of 22,134,362. finvector.com has an estimated worth of US$ 478,185, based on its estimated Ads revenue. finvector.com receives approximately 55,176 unique visitors each day. Its web server is located in Finland, with IP address 185.6.181.240. According to SiteAdvisor, finvector.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$478,185 |
| Daily Ads Revenue | US$442 |
| Monthly Ads Revenue | US$13,243 |
| Yearly Ads Revenue | US$158,905 |
| Daily Unique Visitors | 3,679 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| finvector.com. | A | 3597 | IP: 185.6.181.240 |
| finvector.com. | NS | 3600 | NS Record: ns3.dnadns.fi. |
| finvector.com. | NS | 3600 | NS Record: ns1.dnadns.fi. |
| finvector.com. | NS | 3600 | NS Record: ns2.dnadns.fi. |
| finvector.com. | MX | 3600 | MX Record: 0 finvector-com.mail.protection.outlook.com. |
| finvector.com. | TXT | 3600 | TXT Record: MS=ms98363765 |
| finvector.com. | TXT | 3600 | TXT Record: atlassian-domain-verification=zxKgvP5/VZWLM/5aqyLU3sfsKoNJesVvDzVP0I4qEnAfc0dmSaAR4iJ6w9e4Mcd5 |
| finvector.com. | TXT | 3600 | TXT Record: v=spf1 ip4:185.50.89.51 ip4:62.183.196.218/32 include:spf.protection.outlook.com include:mail.webropolsurveys.com -all |
HtmlToTextCheckTime:2023-05-11 01:52:24
| Our Story Management Services + Cell banking and Viral seed stocks Research & Development Platform Process Development / Scale Up Assay Development and Analytical Testing FinVector Aseptic Filling Capability Stability Studies Viral Vectors (including Adeno, AAV, Lenti) Regulatory GMP Manufacturing Careers + Career Stories Recruitment Videos News & Events Contact FAQ Cubescom A world leader in cGMP manufacturing of Viral-Based Gene Therapy products About us Where ideas become reality! Our state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an unparalleled reputation in the gene therapy market. Services 11.04.2023 FinVector welcomes a New Managing Director to Kuopio 19.12.2022 A Major Milestone for FinVector Following U.S. FDA Approval for Bladder Cancer Gene Therapy Ferring Pharmaceuticals, an affiliate company of Kuopio-based FinVector Oy, has announced the U.S. FDA approval of a new |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx/1.14.0 (Ubuntu) Date: Wed, 03 Nov 2021 20:26:53 GMT Content-Type: text/html Content-Length: 194 Connection: keep-alive Location: http://www.finvector.com/ HTTP/1.1 301 Moved Permanently Content-Type: text/html Content-Length: 0 Connection: keep-alive Status: 301 Moved Permanently Location: https://www.finvector.com/ Date: Wed, 03 Nov 2021 20:26:53 GMT X-Powered-By: Phusion Passenger 6.0.5 Server: nginx/1.14.0 + Phusion Passenger 6.0.5 HTTP/2 200 content-type: text/html; charset=utf-8 status: 200 OK cache-control: public strict-transport-security: max-age=15552000; includeSubDomains x-xss-protection: 1; mode=block x-request-id: dda9d7b7-2b8f-4070-8362-289b04f9a957 etag: W/"fa56f8122723eb3b5a149505a1a46f7e" x-frame-options: SAMEORIGIN x-runtime: 0.305692 x-content-type-options: nosniff date: Wed, 03 Nov 2021 20:26:54 GMT set-cookie: _finvector_session=MGpXWUhOK21FWWh3djBCcmhybStPblo4QXk3d3M1WlplQ2FydzZMeUhkeU9XYzE3WE5MZ3ZPZzFyYzV5NkdyVWdhcmx2WFc4VDY2VkN5MmMwSVNONXZyR1c1QVI3TjBmczNrajl3ZDhxa3ZsajdtQ29Dd2V5a2EvWFVXaXQrYlZuc2ZqVzBLNGwzaDhTR3RpWlJEc0dTSzdTY3NJVW5VNkJDb1I0ajNSY0lSY1RSajlEcjdkblllTVJWTC9KL2ZHLS03VER4VWFhUjBCM3NmWnhraHBDU1NnPT0%3D--27fc1732aa6c1b3e1c0ae1894c8eb00091124e03; path=/; secure; HttpOnly x-powered-by: Phusion Passenger 6.0.5 server: nginx/1.14.0 + Phusion Passenger 6.0.5 |
finvector.com Whois Information
Domain Name: FINVECTOR.COM Registry Domain ID: 1793253817_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-03-28T08:47:04Z Creation Date: 2013-04-12T11:31:58Z Registry Expiry Date: 2022-04-12T11:31:58Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.DNADNS.FI Name Server: NS2.DNADNS.FI Name Server: NS3.DNADNS.FI DNSSEC: unsigned >>> Last update of whois database: 2021-10-13T07:18:47Z <<< |